Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam
Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Betamethasone Valerate Foam.
APLLTD
ALEMBICLTD
Pharmaceuticals
General
Markets